HCPCS Level II · retired code
J9058 — Injection, bendamustine hydrochloride (apotex), 1 mg
J9058 was retired on Dec 31, 2024
CMS ended J9058 after Dec 31, 2024. Don’t report it for later dates of service. Current codes for the same drug:
- J9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
- J9034Injection, bendamustine hcl (bendeka), 1 mg
- J9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9056Injection, bendamustine hydrochloride (vivimusta), 1 mg
- J9066Injection, bendamustine hydrochloride (avyxa), 1 mg
Code
CMS HCPCS fileHCPCS codeJ9058
Billing unit1 mg
- Descriptor
- Injection, bendamustine hydrochloride (apotex), 1 mg
- Short descriptor
- Inj apotex/bendamustine 1 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2025
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Find the NDC
Med-Code hasn’t mapped J9058 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
J9058: common questions
- Is J9058 a CPT code?
- No. J9058 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is one billing unit of J9058?
- One unit of J9058 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.